483
AstraZeneca Pharmaceuticals, LPFDA 483 - AstraZeneca Pharmaceuticals, LP - January 30, 2018
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
AstraZeneca Pharmaceuticals, LP in Gaithersburg, MD, was inspected from January 25-30, 2018. The inspection revealed a significant compliance issue where the firm failed to report all serious and unexpected adverse drug experiences to the FDA within the required 15 calendar days. This indicates deficiencies in their pharmacovigilance reporting processes.
Open in Dashboard
ID · 802dcb0f-4c3f-4e36-b64f-e85ed202036f